Cyclodextrin-modified polyethylenimine polymers for gene delivery.
about
FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERYCyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics.Cell transfection with a β-cyclodextrin-PEI-propane-1,2,3-triol nanopolymerDiscovery of cationic polymers for non-viral gene delivery using combinatorial approaches.Characterization of polyethylenimine by electrospray ionization and matrix-assisted laser desorption/ionization.Lipid and polymeric carrier-mediated nucleic acid delivery.Cyclodextrin-based pharmaceutics: past, present and future.How can macromolecular crowding inhibit biological reactions? The enhanced formation of DNA nanoparticles.Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.Surface-Mediated Delivery of DNA: Cationic Polymers Take ChargeA novel co-polymer based on hydroxypropyl alpha-cyclodextrin conjugated to low molecular weight polyethylenimine as an in vitro gene delivery vectorA dual wavelength-activatable gold nanorod complex for synergistic cancer treatmentNovel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.Discovery and characterization of a new cell-penetrating protein.Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveRNA interference as an anticancer therapy: a patent perspective.Synthesis of β-cyclodextrin containing copolymer via "click" chemistry and its self-assembly in the presence of guest compounds.Degradable polyethylenimines as DNA and small interfering RNA carriers.Cyclodextrin-based gene delivery systems.Polyrotaxanes for applications in life science and biotechnology.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Cationic polymers and their therapeutic potential.Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.Therapeutic potential of siRNA and DNAzymes in cancer.Overcoming obstacles in microRNA delivery towards improved cancer therapy.Caveolae-mediated endocytosis of conjugated polymer nanoparticles.Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications.RNA interference technology with emphasis on delivery vehicles-prospects and limitations.Synergistic induction of apoptosis in brain cancer cells by targeted codelivery of siRNA and anticancer drugs.History of Polymeric Gene Delivery Systems.Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.Single vehicular delivery of siRNA and small molecules to control stem cell differentiationDesign and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.Cell line specific control of polyethylenimine-mediated transient transfection optimized with "Design of experiments" methodology.Diol glycidyl ether-bridged cyclens: preparation and their applications in gene delivery.Biodegradable cross-linked poly(amino alcohol esters) based on LMW PEI for gene delivery.Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET.Sunflower-shaped cyclodextrin-conjugated poly(epsilon-lysine) polyplex as a controlled intracellular trafficking device.Formulation of a peptide nucleic acid based nucleic acid delivery construct.
P2860
Q30472645-3C41A9AB-A1CD-46DD-8102-3743B769925AQ30574647-35A37692-D6B6-4524-B797-745020290CCEQ33793474-13CFD1DD-95DE-4309-85B2-6314B3E445AEQ33993334-86D20545-59BB-4679-B5DF-0BE9F4CF02BFQ34019309-0CBFB266-C562-455F-80A7-F8FCE0ABB63FQ34155795-4BF49A0F-FD8C-4419-9265-2538D6C10CD8Q34552997-F2F718DE-77A8-43AB-AAEE-621715F48966Q36605957-B3A1883B-55B8-4BB9-8B78-E72CD14AA176Q36752048-230A540E-15BF-4F79-9048-FFD3ABD19557Q36919338-A28C9F9F-4F20-453A-8751-FFD225794A1EQ37052045-0DBBC0AB-6FCA-483B-B799-13457137F885Q37083253-7DCC3F9E-30AE-4BC7-A07B-743101115C37Q37206530-4D8771AA-2A5B-4037-8AE4-AE9519F247B4Q37305770-5907578E-0460-444B-9BD3-DBBF60FB758EQ37407912-EAC2BDB5-E0D7-4BC5-8917-3A4CADFA0209Q37454370-D757695D-AF1A-4D24-9383-271171F75634Q37481329-8416BCDF-CA4A-4EF7-8063-19E3293A665CQ37483491-64B45320-A49A-4C02-9F22-A64935E97312Q37532552-3AF51296-7A97-45B7-97E8-A5F30CBCC5B4Q37806096-36DA02B0-9199-4125-98E4-162F8280BF50Q37848225-A60D205A-5656-4CB4-B992-FF7AFD7356A9Q38028961-252EEFBD-3F0F-4D2A-BBC0-82667C9EAE46Q38033969-F24DD8B8-F915-42C7-B501-61BD8F9D8B02Q38106032-712E2D48-2D4A-4055-8666-C4F608B1FF48Q38242397-A6318A96-48AF-4668-8211-A74F6D584F71Q38382967-54B7142A-BE71-4995-978C-40BEDDCFFBCAQ38450870-4CCB5144-DB38-43BD-8B9B-F349DAA3A0A6Q38507265-93EC45CF-522E-4437-9F5C-838EC751C011Q38542435-A7184DBE-81F0-4B0E-9D4D-26ACE6A6C87CQ38610488-46AC976D-08D1-4FFC-A40E-B19A62DAA61FQ38759514-F94F81C0-791C-4544-8627-DFBECF923189Q39038930-AB7FC0C8-6D8A-4261-AAC1-4BC2A1D81431Q39084171-8D7E1411-AC69-48A8-9265-EE27EC22AB7BQ39168927-1463E16F-E906-4A36-95EA-791475011A1EQ39457219-AA0DA069-89D7-4376-BA65-F54DAFA8B71EQ39588291-D8CB463C-4D31-45A8-81FA-C5852352AF08Q39599309-006E3D2F-27F1-4233-BED1-706342093F0DQ40027542-5542A8E3-92B0-4801-AC3D-E7A630D3FC9DQ40362446-0F5EC4D2-3948-4D88-BAC4-7AC0373334E4Q41444330-50DDCDBF-0419-4D64-A0FC-F5D0F391BD96
P2860
Cyclodextrin-modified polyethylenimine polymers for gene delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cyclodextrin-modified polyethylenimine polymers for gene delivery.
@en
type
label
Cyclodextrin-modified polyethylenimine polymers for gene delivery.
@en
prefLabel
Cyclodextrin-modified polyethylenimine polymers for gene delivery.
@en
P2093
P356
P1476
Cyclodextrin-modified polyethylenimine polymers for gene delivery.
@en
P2093
Erlinda Quijano
Greg Jensen
Heidrun Engler
Jeremy Heidel
Mark E Davis
Nathalie C Bellocq
Shufen Wen
Suzie H Pun
Thomas Schluep
P304
P356
10.1021/BC049891G
P577
2004-07-01T00:00:00Z